---
title: "Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M funding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292066923.md"
description: "A merger will combine AI-driven precision medicine and a novel anti-CCL24 antibody to advance a Phase 2 RA trial, with a $150M valuation and $30M new investment. The deal aims to create the first precision medicine for RA, leveraging strong data assets and commercial platforms.Original document: Chemomab Therapeutics Press release — Jul. 8 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-08T12:17:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292066923.md)
  - [en](https://longbridge.com/en/news/292066923.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292066923.md)
generator: "portal-rs"
---

# Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M funding

A merger will combine AI-driven precision medicine and a novel anti-CCL24 antibody to advance a Phase 2 RA trial, with a $150M valuation and $30M new investment. The deal aims to create the first precision medicine for RA, leveraging strong data assets and commercial platforms.

Original document: Chemomab Therapeutics Press release — Jul. 8 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CMMB.US](https://longbridge.com/en/quote/CMMB.US.md)

## Related News & Research

- [MoneyMasters Podcast: Rosenberg on Why the AI Boom Is RISKIER Than You Think](https://longbridge.com/en/news/297239245.md)
- [Salesforce Q2 earnings preview: AI and valuation in focus](https://longbridge.com/en/news/296949009.md)
- [AI Winners, Victims, and the One Stock to Sell Now](https://longbridge.com/en/news/297431483.md)
- [AI could become conscious. What if it wants us dead?](https://longbridge.com/en/news/297407337.md)
- [Ecommerce Trends: What's different about Amazon's approach to AI commerce](https://longbridge.com/en/news/297220919.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**